NM_054012.4:c.1128-6_1188dupTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAATTCC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_054012.4(ASS1):c.1128-6_1188dupTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAATTCC(p.Arg398fs) variant causes a frameshift, stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_054012.4 frameshift, stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.1128-6_1188dupTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAATTCC | p.Arg398fs | frameshift_variant, stop_gained | Exon 14 of 15 | ENST00000352480.10 | NP_446464.1 | |
ASS1 | NM_000050.4 | c.1128-6_1188dupTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAATTCC | p.Arg398fs | frameshift_variant, stop_gained | Exon 15 of 16 | NP_000041.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.1128-10_1128-9insTCCTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAAT | intron_variant | Intron 13 of 14 | 1 | NM_054012.4 | ENSP00000253004.6 | |||
ASS1 | ENST00000372393.7 | c.1128-10_1128-9insTCCTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAAT | intron_variant | Intron 14 of 15 | 5 | ENSP00000361469.2 | ||||
ASS1 | ENST00000372394.5 | c.1128-10_1128-9insTCCTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAAT | intron_variant | Intron 14 of 15 | 2 | ENSP00000361471.1 | ||||
ASS1 | ENST00000372386.6 | n.399-10_399-9insTCCTTGCAGCATGAACGTGCAGGGTGATTATGAGCCAACTGATGCCACCGGGTTCATCAACATCAAT | intron_variant | Intron 4 of 5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000274 AC: 4AN: 1460838Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726568
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Citrullinemia Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 495381). This variant is also known as 1127_1128ins67. This premature translational stop signal has been observed in individuals with citrullinemia type I (PMID: 12815590, 23099195, 23246278). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg398Glnfs*7) in the ASS1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 15 amino acid(s) of the ASS1 protein. -
Variant summary: ASS1 c.1128-6_1188dup67 (p.Arg398Glnfs*7) is expected to create a premature stop codon resulting in a truncated or absent protein. The variant was absent in 249548 control chromosomes. c.1128-6_1188dup67 has been reported in the literature in multiple individuals affected with Citrullinemia Type I (Lee_2013, Woo_2013). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 23246278, 23099195). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Citrullinemia type I Pathogenic:2
- -
Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000495381.3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at